Virtual Reality-Supported Autism Education for Nursing Students (VR-AUTISM-NURS)
Effect of a Virtual Reality-Supported Autism Education Program for Nursing Students on Autism-Related Knowledge, Awareness, and Attitudes: A Randomized Controlled Trial
The goal of this clinical trial is to learn if a virtual reality (VR)-supported autism education program improves knowledge, awareness, and attitudes about autism spectrum disorder (ASD) in fourth-year nursing students. The main questions it aims to answer are:
- Does the program increase nursing students' knowledge of autism?
- Does the program increase their awareness of autism and improve their attitudes toward people with autism?
Researchers will compare students who take the program with students who receive no education during the study, to see if the program improves knowledge, awareness, and attitudes, and whether these effects last one month after the program.
Participants will:
- Attend one 90-minute face-to-face session per week for 8 weeks (education group only). Sessions in weeks 1 to 7 use active learning methods such as group work and brainstorming. In week 8, each student watches a short (about 5-minute) 360-degree VR scenario that shows a hospital visit from the point of view of a child with autism, followed by a guided group discussion.
- Complete questionnaires on autism knowledge, awareness, and attitudes before the program, after the program (week 8), and one month later.
Students in the control group will be offered the same program after the study ends.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Background: Nurses working in primary care and child health services are in a key position to recognize early signs of autism spectrum disorder (ASD) and to refer children for timely assessment. However, nursing students often report limited knowledge and low confidence in this area. Immersive virtual reality (VR) allows learners to experience sensory and social situations from the perspective of a child with autism without involving children in the teaching process.
Design: This is a single-center, two-arm, parallel-group, open-label randomized controlled trial with pretest, posttest, and one-month follow-up measurements. The study will be reported according to CONSORT and the CONSORT-Outcomes 2025 extension.
Randomization: After baseline measurement, participants will be allocated 1:1 by simple randomization using a computer-generated sequence (randomizer.org). Randomization will be performed by an independent researcher not involved in delivering the intervention, and the allocation list will be concealed from the research team until assignment is complete. Data will be coded by group (Group A/Group B) and analyzed by a statistician blinded to group allocation.
Intervention content: Weekly modules cover the diagnostic framework of ASD, social communication and interaction, restricted and repetitive behaviors, sensory experience and perspective taking, comorbidities and differential diagnosis, the nurse's role in early identification and referral, and stigma and professional attitudes. Teaching methods include station rotation, six thinking hats, brainstorming, the six-shoe technique, and cooperative learning (inner-outer circle). Week 8 is a simulation session ("A Journey into the World of a Child with Autism") in which students experience an 8-year-old child's hospital visit first in an unadapted and then in an autism-friendly environment, followed by a structured debriefing. Content will be reviewed by autism experts and piloted with nursing students before the trial.
Statistical analysis: Group-by-time effects across the three measurements will be analyzed with two-way repeated-measures ANOVA, or the nonparametric F1-LD-F1 model if assumptions are not met. Analyses will follow the intention-to-treat principle, and missing data will be handled by multiple imputation. Effect sizes (Cohen's d, partial eta squared) will be reported. The significance level is p<0.05.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Fase
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Edanur Tar Bolacalı, PhD
- Numero di telefono: 05332668360
- Email: edanurtar.1107@gmail.com
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Fourth-year student in the Department of Nursing, Faculty of Health Sciences, Kirsehir Ahi Evran University
- Has completed the pediatric (child health and diseases) nursing course
- Has not previously attended a structured education program on autism spectrum disorder
- Agrees to participate voluntarily and signs the informed consent form
- Is able to attend the education sessions and measurements
Exclusion Criteria:
- Known health condition that may prevent the use of virtual reality (e.g., severe motion sickness or vertigo, epilepsy)
- Not completing the baseline (pretest) measurements
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: VR-Supported Autism Education
Participants will attend an 8-week modular autism education program with one 90-minute face-to-face session per week. Weeks 1-7 consist of active learning modules on autism spectrum disorder. Week 8 consists of a virtual reality simulation session followed by a structured debriefing. |
An 8-week program with one 90-minute face-to-face session per week. Weeks 1-7 cover the diagnostic framework of autism spectrum disorder, social communication and interaction, restricted and repetitive behaviors, sensory experience and perspective taking, comorbidities and differential diagnosis, the nurse's role in early identification and referral, and stigma and professional attitudes, using station rotation, six thinking hats, brainstorming, six-shoe technique, and cooperative learning methods. In week 8, each student experiences an approximately 5-minute immersive 360-degree VR scenario of an 8-year-old child's hospital visit from the child's perspective, first in an unadapted and then in an autism-friendly environment, followed by a structured debriefing. |
|
Nessun intervento: Control
Participants will receive no education during the study period and will complete the same questionnaires at the same time points (baseline, week 8, and week 12). They will be offered the same education program after the follow-up measurement. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Autism Knowledge Score (Knowledge about Childhood Autism among Health Workers Questionnaire)
Lasso di tempo: Baseline (before the intervention), week 8 (immediately after the intervention), and week 12 (one month after the intervention)
|
Autism knowledge will be measured with the Turkish version of the Knowledge about Childhood Autism among Health Workers (KCAHW) Questionnaire. It has 19 items covering social interaction, communication, behavioral patterns, and features of the disorder. Each correct answer scores 1 and each incorrect or "don't know" answer scores 0, giving a total score of 0 to 19. Higher scores indicate greater knowledge of childhood autism. |
Baseline (before the intervention), week 8 (immediately after the intervention), and week 12 (one month after the intervention)
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Autism Awareness Score (Autism Awareness Scale)
Lasso di tempo: Baseline (before the intervention), week 8 (immediately after the intervention), and week 12 (one month after the intervention)
|
Autism awareness will be measured with the Autism Awareness Scale, which has 32 items in 7 subscales (restricted interests and repetitive behaviors, social interaction and communication, causes of autism, peer relationships, key elements of intervention, physical characteristics, and early warning signs). Items are rated on a 5-point Likert scale (1 = strongly disagree, 5 = strongly agree), with reverse-scored items, giving a total score of 32 to 160. Higher scores indicate greater awareness of autism. |
Baseline (before the intervention), week 8 (immediately after the intervention), and week 12 (one month after the intervention)
|
|
Attitudes Toward Autism Score (Societal Attitudes Towards Autism Scale)
Lasso di tempo: Baseline (before the intervention), week 8 (immediately after the intervention), and week 12 (one month after the intervention)
|
Attitudes toward autism will be measured with the Turkish version of the Societal Attitudes Towards Autism (SATA) Scale, which has 26 items in 3 subscales (personal distance, knowledge, and social life). Items are rated on a 4-point scale, with reverse-scored items, giving a total score of 26 to 104. Higher scores indicate more positive attitudes toward individuals with autism. |
Baseline (before the intervention), week 8 (immediately after the intervention), and week 12 (one month after the intervention)
|
Collaboratori e investigatori
Sponsor
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Flood LN, Bulgrin A, Morgan BL. Piecing together the puzzle: development of the Societal Attitudes towards Autism (SATA) scale. Journal of Research in Special Educational Needs. 2013;13(2):121-128.
- Batum S, Aydin A. Turkish adaptation of the Societal Attitudes Towards Autism Spectrum Disorder Scale. Dumlupinar University Journal of Institute of Educational Sciences. 2021;5(2):1-24.
- Yazici MS, Karsantik I. Development of the Autism Awareness Scale: a validity and reliability study. Marmara University Ataturk Faculty of Education Journal of Educational Sciences. 2023;58:18-40. doi: 10.15285/maruaebd.1189906
- Gurbuz-Ozgur B, Aksu H, Eser E. Validity and reliability of the Turkish version of the knowledge about childhood autism among health workers questionnaire. Psychiatry and Clinical Psychopharmacology. 2019. doi: 10.1080/24750573.2019.1637326
- Bakare MO, Ebigbo PO, Agomoh AO, Menkiti NC. Knowledge about childhood autism among health workers (KCAHW) questionnaire: description, reliability and internal consistency. Clin Pract Epidemiol Ment Health. 2008 Jun 6;4:17. doi: 10.1186/1745-0179-4-17.
- Gurbuz Ozgur B, Aksu H, Eser E. Effectiveness of an autism spectrum disorder screening and follow-up training program for primary health care professionals in Turkiye. Turk J Pediatr. 2025 Oct 6;67(5):623-633. doi: 10.24953/turkjpediatr.2025.6322.
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- SYO.A3.26.005
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Individual participant data will not be shared publicly because participants were informed in the consent process that their data would be used only by the research team for scientific purposes. Aggregate results will be published in a peer-reviewed journal. De-identified data may be made available by the principal investigator upon reasonable request after publication, subject to ethics committee approval.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .